Analysis of MDPV in blood-determination and interpretation

Journal of Analytical Toxicology

Volumn 37, Issue 5, 2013, Pages 308-312

  Adamowicz, Piotr ^a   Gil, Dominika ^a   Skulska, Agnieszka ^a   Tokarczyk, Bogdan ^a  

^a INSTITUTE OF FORENSIC RESEARCH   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYPYROVALERONE; CATHINONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; AUTOPSY; BLOOD ANALYSIS; BLOOD SAMPLING; CLINICAL ARTICLE; DRUG DEPENDENCE; FEMALE; HUMAN; LIMIT OF DETECTION; LIQUID CHROMATOGRAPHY; MALE; MORTALITY; QUANTITATIVE ANALYSIS; STANDARD; TANDEM MASS SPECTROMETRY; TOXICITY TESTING; TRAFFIC ACCIDENT;

ACCIDENTS, TRAFFIC; ADULT; BENZODIOXOLES; DESIGNER DRUGS; FATAL OUTCOME; FEMALE; HUMANS; MALE; PSYCHOTROPIC DRUGS; PYRROLIDINES; SUBSTANCE ABUSE DETECTION; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 84883039552     PISSN: 01464760     EISSN: 19452403     Source Type: Journal    
DOI: 10.1093/jat/bkt025     Document Type: Article

References (26)

1. (2010) MDPV report. Psychonaut Web Mapping Research Group. http://www.nascsa.org/news/psychonautmdpvreport.pdf (accessed 11 November 2012).
2. (2010) Advisory Council on the Misuse of Drugs/ACMD consideration of the cathinones. http://www.homeoffice.gov.uk/publications/ drugs/acmd1/acmd-cathinodes-report-2010?view= Binary (accessed 11 November 2012).
3. Erowid. The vaults of erowid. 3,4-Methylenedioxypyrovalerone (MDPV). http://www.erowid.org/chemicals/mdpv/mdpv.shtml (accessed 11 November 2012).
4. Google Trends. http://www.google.com/trends/explore?hl=en- GB#q=mdpv (accessed 11 November 2012).
5. Zuba, D., Byrska, B.; Prevalence, co-existence of active components of "legal highs"; Drug Testing and Analysis, May 1, 2012: 10.1002/ dta.1365.
6. Murray, B.L., Murphy, C.M., Beuhler, M.C. (2012) Death following recreational use of designer drug "bath salts" containing 3,4-methylenedioxypyrovalerone (MDPV). Journal of Medical Toxicology, 8, 69-75.
7. Coppola, M., Mondola, R. (2012) 3,4-methylenedioxypyrovalerone (MDPV): Chemistry, pharmacology and toxicology of a new designer drug of abuse marketed online. Toxicology Letters, 208, 12-15.
8. Baselt, R., Disposition of toxic drugs and chemicals in man. Biomedical Publications, Seal Beach, CA. http://www. biomedicalpublications.com/MDPV.pdf (accessed 11 November 2012).
9. Watterson, L.R., Kufahl, P.R., Nemirovsky, N.E., Sewalia, K., Grabenauer, M., Thomas, B.F. et al.; Potent rewarding and reinforcing effects of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV); Addiction Biology, July 11, 2012: 10.1111/j.1369-1600. 2012.00474.x.
10. Baumann, M.H., Partilla, J.S., Lehner, K.R., Thorndike, E.B., Hoffman, A.F., Holy, M. et al.; Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive 'bath salts' products; Neuropsychopharmacology, October 17, 2012: 10.1038/npp.2012.204.
11. Simmler, L.D., Buser, T.A., Donzelli, M., Schramm, Y., Dieu, L.H., Huwyler, J. et al. (2013) Pharmacological characterization of designer cathinones in vitro. British Journal of Pharmacology, 168, 458-470.
12. Ross, E.A., Reisfield, G.M., Watson, M.C., Chronister, C.W., Goldberger, B.A. (2012) Psychoactive "bath salts" intoxication with methylenedioxypyrovalerone. American Journal of Medicine, 125, 854-858.
13. Borek, H.A., Holstege, C.P. (2012) Hyperthermia and multiorgan failure after abuse of "bath salts" containing 3,4-methylenedioxypyrovalerone. Annals of Emergency Medicine, 60, 103-105.
14. Kyle, P.B., Iverson, R.B., Gajagowni, R.G., Spencer, L. (2011) Illicit bath salts: Not for bathing. Journal of the Mississippi State Medical Association, 52, 375-377.
15. Penders, T.M., Gestring, R.E., Vilensky, D.A. (2012) Intoxication delirium following use of synthetic cathinone derivatives. The American Journal of Drug Alcohol Abuse, 38, 617-618.
16. Zuba, D., Adamowicz, P., Byrska, B.; Detection of buphedrone in biological, non-biological material-Two case reports; Forensic Science International, September 13, 2012: 10.1016/j.forsciint.2012.08.034.
17. Kriikku, P., Wilhelm, L., Schwarz, O., Rintatalo, J. (2011) New designer drug of abuse: 3,4-Methylenedioxypyrovalerone (MDPV). Findings from apprehended drivers in Finland. Forensic Science International, 210, 195-200.
18. Kriikku, P., Wilhelm, L., Schwarz, O., Rintatalo, J., Ojanpera, I., Vuori, E. et al. (2011) Methylenedioxypyrovalerone (MDPV) in Finland. Toxichem Krimtech, 78, 293-296.
19. Marusich, J.A., Grant, K.R., Blough, B.E., Wiley, J.L. (2012) Effects of synthetic cathinones contained in "bath salts" on motor behavior and a functional observational battery in mice. Neurotoxicology, 33, 1305-1313.
20. Huang, P.K., Aarde, S.M., Angrish, D., Houseknecht, K.L., Dickerson, T.J., Taffe, M.A. (2012) Contrasting effects of d-methamphetamine, 3,4-methylenedioxymethamphetamine, 3,4-methylenedioxypyrovalerone, and 4-methylmethcathinone on wheel activity in rats. Drug and Alcohol Dependence, 126, 168-175.
21. Richards-Waugh, L.L., Bailey, K.M., Gebhardt, M.A., Clay, D.J., Newsome-Sparks, C.L., Mahmoud, H.E. et al. Bizarre behavior and death following ingestion of MDPV ("bath salts"). Presented at the annual meeting of the International Association of Forensic Toxicologists, San Francisco, California, September 29, 2011.
22. Wyman, J.F., Lavins, E.S., Sofalvi, S., Armstrong, E.J., Engelhart, D.A., Boggs, P.D. et al. Death by "bath salts": Postmortem tissue distribution of MDPV following lethal intoxication. Presented at the annual meeting of the International Association of Forensic Toxicologists, San Francisco, California, September 29, 2011.
23. Spiller, H.A., Ryan, M.L., Weston, R.G., Jansen, J. (2011) Clinical experience with and analytical confirmation of "bath salts" and "legal highs" (synthetic cathinones) in the United States. Clinical Toxicology, 49, 499-505.
24. Spencer, J.W., Long, C., Scalzo, A.J., Weber, J.A., Crifasi, J., Halcomb, S. et al. (2011) Acute psychiatric, cardiopulmonary, and neurologic effects of laboratory-confirmed use of methylenedioxypyrovalerone (MDPV) "bath salts." Presented at the NACCT Congress, Washington DC, September 23-26, 2011. http://www.clintox.org/NACCT/ 2011/NACCT2011abstractsAllPoster.pdf (accessed 11 November 2012).
25. Thornton, S.L., Gerona, R.R., Tomaszewski, C.A. (2012) Psychosis from a bath salt product containing flephedrone and MDPV with serum, urine, and product quantification. Journal of Medical Toxicology, 8, 310-313.
26. Alexy, E.M., Labay, L.M., Corvo, J. Bioanalytical quantification of MDPV: A paranoia inducing designer stimulant. Presented at the annual meeting of the International Association of Forensic Toxicologists, San Francisco, California, September 29, 2011.